Bobbak Mansouri


FDA Approves New Medication for Plaque Psoriasis

FDA Approves New Medication for Plaque Psoriasis   On January 1, 2015, the United States Food & Drug Administration approved Cosentyx (secukinumab) for use in moderate to severe plaque psoriasis. Cosentyx is the first injectable medication approved for psoriasis which targets IL-17A, a molecule responsible for psoriatic inflammation. The safety […]


Psoriasis Nails

Nail Psoriasis Treatment – National Psoriasis Foundation’s Recommendations

Nail Psoriasis Treatment – Published Guidelines Nail psoriasis is a burden to many psoriasis patients, is difficult to treat, and has no standardized treatment algorithm. The Medical Board of the National Psoriasis Foundation recently published guidelines for the treatment of nail psoriasis. These treatment recommendations spanned four nail psoriasis scenarios […]